Differential effects of immunosuppressive drugs on T-cell motility

A Datta, R David, S Glennie, D Scott, E Cernuda-Morollon, R I Lechler, A J Ridley, F M Marelli-Berg

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)

Abstract

The best-characterized mechanism of the action of immunosuppressive drugs is to prevent T-cell clonal expansion, thus containing the magnitude of the ensuing immune response. As T-cell recruitment to the inflammatory site is another key step in the development of T-cell-mediated inflammation, we analyzed and compared the effects of two commonly used immunosuppressants, cyclosporin A (CsA) and the rapamycin-related compound SDZ-RAD, on the motility of human CD4+ T cells. We show that CsA, but not SDZ-RAD, inhibits T-cell transendothelial migration in vitro. CsA selectively impaired chemokine-induced T-cell chemotaxis while integrin-mediated migration was unaffected. The inhibition of T-cell chemotaxis correlated with reduced AKT/PKB but not ERK activation following exposure to the chemokine CXCL-12/SDF-1. In addition, CsA, but not SDZ-RAD, prevents some T-cell receptor-mediated effects on T-cell motility. Finally, we show that CsA, but not SDZ-RAD inhibits tissue infiltration by T cells in vivo. Our data suggest a prominent antiinflammatory role for CsA in T-cell-mediated tissue damage, by inhibiting T-cell trafficking into tissues in addition to containing clonal expansion
Original languageEnglish
Pages (from-to)2871 - 2883
Number of pages13
JournalAmerican Journal of Transplantation
Volume6
Issue number12
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Dive into the research topics of 'Differential effects of immunosuppressive drugs on T-cell motility'. Together they form a unique fingerprint.

Cite this